AzTrials
AzTrials

Analogue Generalized Anxiety DisorderRETRAIN REP-EXNCT06804629

The Resistance Exercise Training for Worry Trial: Replication and Expansion

A study testing Moderate-to-High Intensity Resistance Exercise Training in people with Analogue Generalized Anxiety Disorder, run by University of Limerick at 1 site in Ireland.

Completed

Finished. The study has ended and is not enrolling. Results may be posted on the official record.

Official record
Search all trials

Trial summary

This protocol details the full methods of a ten-week moderate-to-high intensity, guidelines-based resistance exercise training intervention compared to a low intensity sham attention control among young adult women with analogue Generalized Anxiety Disorder. Read more about this study

Who is it for?
Ages 18 to 40 years, women only
Conditions the study is for
Analogue Generalized Anxiety Disorder
What is being tested?
Moderate-to-High Intensity Resistance Exercise Training
Could I receive a placebo?
Yes, some participants may receive a placebo
How many people
68 participants
Where
1 siteIreland
Study dates
9 Oct 2023to 5 Jan 2025
Phase
Interventional
Are there results?
None posted in the registry

Key requirements

Who can take part, as listed by the sponsor. Only the study team can confirm whether you are eligible, so take this list to your doctor.

  • Ages 18 to 40 years
  • Women only
  • No healthy volunteers
  • Adult

Who may be able to join

  • Female
  • Aged 18-40y
  • Met criteria for analogue Generalized Anxiety Disorder

Who cannot join

  • Medical contraindications to doing resistance exercise training
  • Currently involved in formal resistance exercise training
  • Currently pregnant or post-partum

Trial locations and contacts

1 site in 1 country.

Ireland1 site
  • University of Limerick

    Limerick, Munster, V94 T9PX

Other trials in Ireland

About this study

Official title: Acute and Chronic Effects of Guidelines-Based Resistance Exercise Training Compared to a Low Intensity SHAM Attention Control Among Young Adult Women With Analogue Generalized Anxiety Disorder: A Protocol for a Randomized Controlled Trial.

This protocol details the full methods of a ten-week moderate-to-high intensity, guidelines-based resistance exercise training intervention compared to a low intensity sham attention control among young adult women with analogue Generalized Anxiety Disorder.

Read the detailed description

A recent clinical trial supported the anxiolytic effects of regularly-performed resistance exercise training compared to a waitlist control among young adults with and without at least subclinical, or analogue, Generalized Anxiety Disorder. Although the evidence to date is promising, waitlist control conditions cannot control for potential social and psychological benefits of engaging with most interventions, including social contact, expectations for improvement, and mastery experiences, which could potentially be achieved from easier activities. Therefore, this trial aims to replicate the previously investigated World Health Organization and American College of Sports Medicine guidelines-based resistance exercise training program, and expand on this research by more rigorously examining the effects on anxiety and worry symptoms, independent of potential social and psychological benefits of engagement with the intervention. Consequently, this trial quantifies the acute and chronic effects of moderate-to-high intensity, guidelines-based resistance exercise training compared to a low intensity SHAM attention control on signs and symptoms of Generalized Anxiety Disorder among at-risk young adult women with Analogue Generalized Anxiety Disorder. This trial consists of a two-week familiarization protocol, eight weeks of formal resistance exercise training, and a one-month post-intervention follow-up.

Being tested
Moderate-to-High Intensity Resistance Exercise Training, Low Intensity SHAM Resistance Exercise Training Attention Control
Keywords
Analogue Generalized Anxiety Disorder, Young adults, Female, Worry, Strength training, Resistance training

What participants receive

What participants receive. In a randomised study each person is assigned to one group by chance.

  • Moderate-to-High Intensity Resistance Exercise TrainingBehavioural

    Also called Strength training, Weight-lifting

    Resistance exercise training was designed in accordance with World Health Organization and American College of Sports Medicine guidelines. The eight-week, twice-weekly intervention was designed such that moderate-to-high intensity participants could achieve two sets of 8-12 repetitions of the eight exercises before volitional fatigue, a deterioration in lifting form, or failure to complete a repetition, using loads of approximately 70-80% of their estimated one-repetition maximum. Completed in the following order, the exercises were: barbell back squat, barbell bench press, hexagon bar deadlift, barbell bent over row, dumbbell lunges, seated dumbbell lateral raises, weighted or unweighted abdominal crunches, and seated dumbbell bicep curls. There was one minute of rest between each set, and two minutes of rest between each exercise. If participants could complete two sets of 12 repetitions, load was increased gradually by approximately 5% in the following session.

  • Low Intensity SHAM Resistance Exercise Training Attention ControlBehavioural

    The low intensity SHAM condition was matched all features of engagement with the moderate-to-high intensity intervention apart from load, and load progression. Low intensity SHAM participants completed the same program with loads of approximately 20% of their estimated one-repetition maximum. To maintain low intensity, repetitions completed on the main, heavier lifts (i.e., back squat, bench press, deadlift, bent over row) were increased from 10 in one session to 12 in the next; load was then increased by approximately 10% in the following session, and 10 reps were performed again. On the remaining lighter, assistance lifts, eight repetitions were performed per set, then one repetition was added to both sets in each session, and load was increased by the smallest increment possible when two sets of 12 repetitions were performed. Borg's 6-20 rating of perceived exertion scores were used to monitor intensity, such that if scores exceeded 11, load and reps were not progressed.

Study groups in NCT06804629
Study groupRoleWhat they receive
Moderate-to-High Intensity Resistance Exercise TrainingExperimentalModerate-to-high intensity, guidelines-based resistance exercise training completed at 70-80% of the estimated one-repetition maximum
Receives: Behavioral: Moderate-to-High Intensity Resistance Exercise Training
Low Intensity SHAM Resistance Exercise Training Attention ControlSham comparatorLow intensity SHAM Resistance Exercise Training completed at 20% of the estimated one-repetition maximum
Receives: Behavioral: Low Intensity SHAM Resistance Exercise Training Attention Control

What is being measured

The primary outcome is the main question the study is designed to answer.

  1. Analogue Generalized Anxiety Disorder Status

    Psychiatric Diagnostic Screening Questionnaire Generalized Anxiety Disorder subscale score of 6 or greater (Zimmerman \& Mattia, 2001)

    Measured: Baseline

  2. Analogue Generalized Anxiety Disorder Status

    Psychiatric Diagnostic Screening Questionnaire Generalized Anxiety Disorder subscale score of 6 or greater (Zimmerman \& Mattia, 2001)

    Measured: Week 1

  3. Analogue Generalized Anxiety Disorder Status

    Psychiatric Diagnostic Screening Questionnaire Generalized Anxiety Disorder subscale score of 6 or greater (Zimmerman \& Mattia, 2001)

    Measured: Week 4

  4. Analogue Generalized Anxiety Disorder Status

    Psychiatric Diagnostic Screening Questionnaire Generalized Anxiety Disorder subscale score of 6 or greater (Zimmerman \& Mattia, 2001)

    Measured: Week 8

  5. Analogue Generalized Anxiety Disorder Status

    Psychiatric Diagnostic Screening Questionnaire Generalized Anxiety Disorder subscale score of 6 or greater (Zimmerman \& Mattia, 2001)

    Measured: Week 12

  6. Analogue Generalized Anxiety Disorder Status

    Penn State Worry Questionnaire of 45 or greater (Meyer et al., 1990)

    Measured: Baseline

  7. Analogue Generalized Anxiety Disorder Status

    Penn State Worry Questionnaire of 45 or greater (Meyer et al., 1990)

    Measured: Week 1

  8. Analogue Generalized Anxiety Disorder Status

    Penn State Worry Questionnaire of 45 or greater (Meyer et al., 1990)

    Measured: Week 4

  9. Analogue Generalized Anxiety Disorder Status

    Penn State Worry Questionnaire of 45 or greater (Meyer et al., 1990)

    Measured: Week 8

  10. Analogue Generalized Anxiety Disorder Status

    Penn State Worry Questionnaire of 45 or greater (Meyer et al., 1990)

    Measured: Week 12

  11. Worry Symptoms

    16-item Penn State Worry Questionnaire (Meyer et al., 1990)

    Measured: Baseline

  12. Worry Symptoms

    16-item Penn State Worry Questionnaire (Meyer et al., 1990)

    Measured: Pre-week 1

  13. Worry Symptoms

    16-item Penn State Worry Questionnaire (Meyer et al., 1990)

    Measured: Week 1

  14. Worry Symptoms

    16-item Penn State Worry Questionnaire (Meyer et al., 1990)

    Measured: Week 2

  15. Worry Symptoms

    16-item Penn State Worry Questionnaire (Meyer et al., 1990)

    Measured: Week 3

  16. Worry Symptoms

    16-item Penn State Worry Questionnaire (Meyer et al., 1990)

    Measured: Week 4

  17. Worry Symptoms

    16-item Penn State Worry Questionnaire (Meyer et al., 1990)

    Measured: Week 5

  18. Worry Symptoms

    16-item Penn State Worry Questionnaire (Meyer et al., 1990)

    Measured: Week 6

  19. Worry Symptoms

    16-item Penn State Worry Questionnaire (Meyer et al., 1990)

    Measured: Week 7

  20. Worry Symptoms

    16-item Penn State Worry Questionnaire (Meyer et al., 1990)

    Measured: Week 8

  21. Worry Symptoms

    16-item Penn State Worry Questionnaire (Meyer et al., 1990)

    Measured: Week 12

Secondary outcomes (109)
  1. Anxiety Symptoms

    Trait anxiety was measured using the Trait (STAI-Y2) subscale of the State-Trait Anxiety Inventory (Spielberger, 2010)

    Measured: Baseline

  2. Anxiety Symptoms

    Trait anxiety was measured using the Trait (STAI-Y2) subscale of the State-Trait Anxiety Inventory (Spielberger, 2010)

    Measured: Pre-week 1

  3. Anxiety Symptoms

    Trait anxiety was measured using the Trait (STAI-Y2) subscale of the State-Trait Anxiety Inventory (Spielberger, 2010)

    Measured: Week 1

  4. Anxiety Symptoms

    Trait anxiety was measured using the Trait (STAI-Y2) subscale of the State-Trait Anxiety Inventory (Spielberger, 2010)

    Measured: Week 2

  5. Anxiety Symptoms

    Trait anxiety was measured using the Trait (STAI-Y2) subscale of the State-Trait Anxiety Inventory (Spielberger, 2010)

    Measured: Week 3

  6. Anxiety Symptoms

    Trait anxiety was measured using the Trait (STAI-Y2) subscale of the State-Trait Anxiety Inventory (Spielberger, 2010)

    Measured: Week 4

  7. Anxiety Symptoms

    Trait anxiety was measured using the Trait (STAI-Y2) subscale of the State-Trait Anxiety Inventory (Spielberger, 2010)

    Measured: Week 5

  8. Anxiety Symptoms

    Trait anxiety was measured using the Trait (STAI-Y2) subscale of the State-Trait Anxiety Inventory (Spielberger, 2010)

    Measured: Week 6

  9. Anxiety Symptoms

    Trait anxiety was measured using the Trait (STAI-Y2) subscale of the State-Trait Anxiety Inventory (Spielberger, 2010)

    Measured: Week 7

  10. Anxiety Symptoms

    Trait anxiety was measured using the Trait (STAI-Y2) subscale of the State-Trait Anxiety Inventory (Spielberger, 2010)

    Measured: Week 8

  11. Anxiety Symptoms

    Trait anxiety was measured using the Trait (STAI-Y2) subscale of the State-Trait Anxiety Inventory (Spielberger, 2010)

    Measured: Week 12

  12. Anxiety Symptoms

    State anxiety was measured using the State (STAI-Y1) subscale of the State-Trait Anxiety Inventory (Spielberger, 2010)

    Measured: Baseline

  13. Anxiety Symptoms

    State anxiety was measured using the State (STAI-Y1) subscale of the State-Trait Anxiety Inventory (Spielberger, 2010)

    Measured: Pre-acute resistance exercise bout week 1

  14. Anxiety Symptoms

    State anxiety was measured using the State (STAI-Y1) subscale of the State-Trait Anxiety Inventory (Spielberger, 2010)

    Measured: Post-acute resistance exercise bout week 1

  15. Anxiety Symptoms

    State anxiety was measured using the State (STAI-Y1) subscale of the State-Trait Anxiety Inventory (Spielberger, 2010)

    Measured: Pre-acute resistance exercise bout week 8

  16. Anxiety Symptoms

    State anxiety was measured using the State (STAI-Y1) subscale of the State-Trait Anxiety Inventory (Spielberger, 2010)

    Measured: Post-acute resistance exercise bout week 8

  17. Depressive Symptoms

    16-item Quick Inventory of Depressive Symptomatology (Rush et al., 2003)

    Measured: Baseline

  18. Depressive Symptoms

    16-item Quick Inventory of Depressive Symptomatology (Rush et al., 2003)

    Measured: Pre-week 1

  19. Depressive Symptoms

    16-item Quick Inventory of Depressive Symptomatology (Rush et al., 2003)

    Measured: Week 1

  20. Depressive Symptoms

    16-item Quick Inventory of Depressive Symptomatology (Rush et al., 2003)

    Measured: Week 2

  21. Depressive Symptoms

    16-item Quick Inventory of Depressive Symptomatology (Rush et al., 2003)

    Measured: Week 3

  22. Depressive Symptoms

    16-item Quick Inventory of Depressive Symptomatology (Rush et al., 2003)

    Measured: Week 4

  23. Depressive Symptoms

    16-item Quick Inventory of Depressive Symptomatology (Rush et al., 2003)

    Measured: Week 5

  24. Depressive Symptoms

    16-item Quick Inventory of Depressive Symptomatology (Rush et al., 2003)

    Measured: Week 6

  25. Depressive Symptoms

    16-item Quick Inventory of Depressive Symptomatology (Rush et al., 2003)

    Measured: Week 7

  26. Depressive Symptoms

    16-item Quick Inventory of Depressive Symptomatology (Rush et al., 2003)

    Measured: Week 8

  27. Depressive Symptoms

    16-item Quick Inventory of Depressive Symptomatology (Rush et al., 2003)

    Measured: Week 12

  28. Mood

    Subscales of the Profile of Mood States - Brief Form (McNair et al., 1992)

    Measured: Baseline

  29. Mood

    Subscales of the Profile of Mood States - Brief Form (McNair et al., 1992)

    Measured: Pre-week 1

  30. Mood

    Subscales of the Profile of Mood States - Brief Form (McNair et al., 1992)

    Measured: Week 1

  31. Mood

    Subscales of the Profile of Mood States - Brief Form (McNair et al., 1992)

    Measured: Week 2

  32. Mood

    Subscales of the Profile of Mood States - Brief Form (McNair et al., 1992)

    Measured: Week 3

  33. Mood

    Subscales of the Profile of Mood States - Brief Form (McNair et al., 1992)

    Measured: Week 4

  34. Mood

    Subscales of the Profile of Mood States - Brief Form (McNair et al., 1992)

    Measured: Week 5

  35. Mood

    Subscales of the Profile of Mood States - Brief Form (McNair et al., 1992)

    Measured: Week 6

  36. Mood

    Subscales of the Profile of Mood States - Brief Form (McNair et al., 1992)

    Measured: Week 7

  37. Mood

    Subscales of the Profile of Mood States - Brief Form (McNair et al., 1992)

    Measured: Week 8

  38. Mood

    Subscales of the Profile of Mood States - Brief Form (McNair et al., 1992)

    Measured: Week 12

  39. Mood

    Subscales of the Profile of Mood States - Brief Form (McNair et al., 1992)

    Measured: Pre-acute resistance exercise bout week 1

  40. Mood

    Subscales of the Profile of Mood States - Brief Form (McNair et al., 1992)

    Measured: Post-acute resistance exercise bout week 1

  41. Mood

    Subscales of the Profile of Mood States - Brief Form (McNair et al., 1992)

    Measured: Pre-acute resistance exercise bout week 8

  42. Mood

    Subscales of the Profile of Mood States - Brief Form (McNair et al., 1992)

    Measured: Post-acute resistance exercise bout week 8

  43. Analogue Major Depressive Disorder Status

    Psychiatric Diagnostic Screening Questionnaire Major Depressive Disorder subscale score of 9 or greater (Zimmerman \& Mattia, 2001)

    Measured: Baseline

  44. Analogue Major Depressive Disorder Status

    Psychiatric Diagnostic Screening Questionnaire Major Depressive Disorder subscale score of 9 or greater (Zimmerman \& Mattia, 2001)

    Measured: Week 1

  45. Analogue Major Depressive Disorder Status

    Psychiatric Diagnostic Screening Questionnaire Major Depressive Disorder subscale score of 9 or greater (Zimmerman \& Mattia, 2001)

    Measured: Week 4

  46. Analogue Major Depressive Disorder Status

    Psychiatric Diagnostic Screening Questionnaire Major Depressive Disorder subscale score of 9 or greater (Zimmerman \& Mattia, 2001)

    Measured: Week 8

  47. Analogue Major Depressive Disorder Status

    Psychiatric Diagnostic Screening Questionnaire Major Depressive Disorder subscale score of 9 or greater (Zimmerman \& Mattia, 2001)

    Measured: Week 12

  48. Analogue Panic Disorder Status

    Psychiatric Diagnostic Screening Questionnaire Panic Disorder subscale score of 4 or greater (Zimmerman \& Mattia, 2001)

    Measured: Baseline

  49. Analogue Panic Disorder Status

    Psychiatric Diagnostic Screening Questionnaire Panic Disorder subscale score of 4 or greater (Zimmerman \& Mattia, 2001)

    Measured: Week 1

  50. Analogue Panic Disorder Status

    Psychiatric Diagnostic Screening Questionnaire Panic Disorder subscale score of 4 or greater (Zimmerman \& Mattia, 2001)

    Measured: Week 4

  51. Analogue Panic Disorder Status

    Psychiatric Diagnostic Screening Questionnaire Panic Disorder subscale score of 4 or greater (Zimmerman \& Mattia, 2001)

    Measured: Week 8

  52. Analogue Panic Disorder Status

    Psychiatric Diagnostic Screening Questionnaire Panic Disorder subscale score of 4 or greater (Zimmerman \& Mattia, 2001)

    Measured: Week 12

  53. Analogue Social Anxiety Disorder Status

    Psychiatric Diagnostic Screening Questionnaire Social Anxiety Disorder subscale score of 4 or greater (Zimmerman \& Mattia, 2001)

    Measured: Baseline

  54. Analogue Social Anxiety Disorder Status

    Psychiatric Diagnostic Screening Questionnaire Social Anxiety Disorder subscale score of 4 or greater (Zimmerman \& Mattia, 2001)

    Measured: Week 1

  55. Analogue Social Anxiety Disorder Status

    Psychiatric Diagnostic Screening Questionnaire Social Anxiety Disorder subscale score of 4 or greater (Zimmerman \& Mattia, 2001)

    Measured: Week 4

  56. Analogue Social Anxiety Disorder Status

    Psychiatric Diagnostic Screening Questionnaire Social Anxiety Disorder subscale score of 4 or greater (Zimmerman \& Mattia, 2001)

    Measured: Week 8

  57. Analogue Social Anxiety Disorder Status

    Psychiatric Diagnostic Screening Questionnaire Social Anxiety Disorder subscale score of 4 or greater (Zimmerman \& Mattia, 2001)

    Measured: Week 12

  58. Sleep Quality

    Pittsburgh Sleep Quality Index (Buysse et al., 1989)

    Measured: Baseline

  59. Sleep Quality

    Pittsburgh Sleep Quality Index (Buysse et al., 1989)

    Measured: Week 1

  60. Sleep Quality

    Pittsburgh Sleep Quality Index (Buysse et al., 1989)

    Measured: Week 4

  61. Sleep Quality

    Pittsburgh Sleep Quality Index (Buysse et al., 1989)

    Measured: Week 8

  62. Sleep Quality

    Pittsburgh Sleep Quality Index (Buysse et al., 1989)

    Measured: Week 12

  63. Irritability Symptoms

    21-item Irritability Questionnaire (Craig et al., 2008)

    Measured: Baseline

  64. Irritability Symptoms

    21-item Irritability Questionnaire (Craig et al., 2008)

    Measured: Week 1

  65. Irritability Symptoms

    21-item Irritability Questionnaire (Craig et al., 2008)

    Measured: Week 4

  66. Irritability Symptoms

    21-item Irritability Questionnaire (Craig et al., 2008)

    Measured: Week 8

  67. Irritability Symptoms

    21-item Irritability Questionnaire (Craig et al., 2008)

    Measured: Week 12

  68. Rumination

    Rumination-Reflection Questionnaire (Trapnell and Campbell, 1999)

    Measured: Baseline

  69. Rumination

    Rumination-Reflection Questionnaire (Trapnell and Campbell, 1999)

    Measured: Week 1

  70. Rumination

    Rumination-Reflection Questionnaire (Trapnell and Campbell, 1999)

    Measured: Week 4

  71. Rumination

    Rumination-Reflection Questionnaire (Trapnell and Campbell, 1999)

    Measured: Week 8

  72. Rumination

    Rumination-Reflection Questionnaire (Trapnell and Campbell, 1999)

    Measured: Week 12

  73. Cognitive Functioning

    Stroop Colour and Word Test (Williams et al., 1996)

    Measured: Baseline

  74. Cognitive Functioning

    Stroop Colour and Word Test (Williams et al., 1996)

    Measured: Pre-acute resistance exercise bout week 1

  75. Cognitive Functioning

    Stroop Colour and Word Test (Williams et al., 1996)

    Measured: Post-acute resistance exercise bout week 1

  76. Cognitive Functioning

    Stroop Colour and Word Test (Williams et al., 1996)

    Measured: Pre-acute resistance exercise bout week 8

  77. Cognitive Functioning

    Stroop Colour and Word Test (Williams et al., 1996)

    Measured: Post-acute resistance exercise bout week 8

  78. Cognitive Functioning

    Stroop Colour and Word Test (Williams et al., 1996)

    Measured: Week 8

  79. Cognitive Functioning

    Trail Making Test (Tombaugh, 2004)

    Measured: Baseline

  80. Cognitive Functioning

    Trail Making Test (Tombaugh, 2004)

    Measured: Pre-acute resistance exercise bout week 1

  81. Cognitive Functioning

    Trail Making Test (Tombaugh, 2004)

    Measured: Post-acute resistance exercise bout week 1

  82. Cognitive Functioning

    Trail Making Test (Tombaugh, 2004)

    Measured: Pre-acute resistance exercise bout week 8

  83. Cognitive Functioning

    Trail Making Test (Tombaugh, 2004)

    Measured: Post-acute resistance exercise bout week 8

  84. Cognitive Functioning

    Trail Making Test (Tombaugh, 2004)

    Measured: Week 8

  85. Resistance Exercise Expectations

    15-item Expected Psychological Outcomes of Resistance Exercise Training (EPO-RET) questionnaire, derived from the Expected Psychological Outcomes of Exercise Questionnaire (Lindheimer et al., 2020). Participants were asked "For each of the below outcomes, think about how you would expect to feel after completing a resistance exercise program (2 sessions per week for 8-12 weeks) relative to how you typically feel".

    Measured: Baseline

  86. Resistance Exercise Expectations

    15-item Expected Psychological Outcomes of Resistance Exercise Training (EPO-RET) questionnaire, derived from the Expected Psychological Outcomes of Exercise Questionnaire (Lindheimer et al., 2020). Participants were asked "For each of the below outcomes, think about how you would expect to feel after completing a resistance exercise program (2 sessions per week for 8-12 weeks) relative to how you typically feel".

    Measured: Week 1

  87. Resistance Exercise Expectations

    15-item Expected Psychological Outcomes of Resistance Exercise Training (EPO-RET) questionnaire, derived from the Expected Psychological Outcomes of Exercise Questionnaire (Lindheimer et al., 2020). Participants were asked "For each of the below outcomes, think about how you would expect to feel after completing a resistance exercise program (2 sessions per week for 8-12 weeks) relative to how you typically feel".

    Measured: Week 4

  88. Resistance Exercise Expectations

    15-item Expected Psychological Outcomes of Resistance Exercise Training (EPO-RET) questionnaire, derived from the Expected Psychological Outcomes of Exercise Questionnaire (Lindheimer et al., 2020). Participants were asked "For each of the below outcomes, think about how you would expect to feel after completing a resistance exercise program (2 sessions per week for 8-12 weeks) relative to how you typically feel".

    Measured: Week 8

  89. Resistance Exercise Expectations

    15-item Expected Psychological Outcomes of Resistance Exercise Training (EPO-RET) questionnaire, derived from the Expected Psychological Outcomes of Exercise Questionnaire (Lindheimer et al., 2020). Participants were asked "For each of the below outcomes, think about how you would expect to feel after completing a resistance exercise program (2 sessions per week for 8-12 weeks) relative to how you typically feel".

    Measured: Week 12

  90. Resistance Exercise Expectations

    15-item Expected Psychological Outcomes of Acute Resistance Exercise (EPO-ARE) derived from the Expected Psychological Outcomes of Exercise Questionnaire (Lindheimer et al., 2020). Participants are asked to "think about how you would expect to feel after one resistance exercise workout relative to how you typically feel".

    Measured: Pre-acute resistance exercise bout week 1

  91. Resistance Exercise Expectations

    15-item Expected Psychological Outcomes of Acute Resistance Exercise (EPO-ARE) derived from the Expected Psychological Outcomes of Exercise Questionnaire (Lindheimer et al., 2020). Participants are asked to "think about how you would expect to feel after one resistance exercise workout relative to how you typically feel".

    Measured: Post-acute resistance exercise bout week 1

  92. Resistance Exercise Expectations

    15-item Expected Psychological Outcomes of Acute Resistance Exercise (EPO-ARE) derived from the Expected Psychological Outcomes of Exercise Questionnaire (Lindheimer et al., 2020). Participants are asked to "think about how you would expect to feel after one resistance exercise workout relative to how you typically feel".

    Measured: Pre-acute resistance exercise bout week 8

  93. Resistance Exercise Expectations

    15-item Expected Psychological Outcomes of Acute Resistance Exercise (EPO-ARE) derived from the Expected Psychological Outcomes of Exercise Questionnaire (Lindheimer et al., 2020). Participants are asked to "think about how you would expect to feel after one resistance exercise workout relative to how you typically feel".

    Measured: Post-acute resistance exercise bout week 8

  94. Physical Activity

    7-day Physical Activity Recall (Blair et al., 1985)

    Measured: Baseline

  95. Physical Activity

    7-day Physical Activity Recall (Blair et al., 1985)

    Measured: Pre-week 1

  96. Physical Activity

    7-day Physical Activity Recall (Blair et al., 1985)

    Measured: Week 1

  97. Physical Activity

    7-day Physical Activity Recall (Blair et al., 1985)

    Measured: Week 2

  98. Physical Activity

    7-day Physical Activity Recall (Blair et al., 1985)

    Measured: Week 3

  99. Physical Activity

    7-day Physical Activity Recall (Blair et al., 1985)

    Measured: Week 4

  100. Physical Activity

    7-day Physical Activity Recall (Blair et al., 1985)

    Measured: Week 5

  101. Physical Activity

    7-day Physical Activity Recall (Blair et al., 1985)

    Measured: Week 6

  102. Physical Activity

    7-day Physical Activity Recall (Blair et al., 1985)

    Measured: Week 7

  103. Physical Activity

    7-day Physical Activity Recall (Blair et al., 1985)

    Measured: Week 8

  104. Physical Activity

    7-day Physical Activity Recall (Blair et al., 1985)

    Measured: Week 12

  105. Muscle-Strengthening Exercise Activity

    Muscle-Strengthening Exercise Questionnaire - Short Version (Shakespear-Druery et al., 2022)

    Measured: Baseline

  106. Muscle-Strengthening Exercise Activity

    Muscle-Strengthening Exercise Questionnaire - Short Version (Shakespear-Druery et al., 2022)

    Measured: Week 1

  107. Muscle-Strengthening Exercise Activity

    Muscle-Strengthening Exercise Questionnaire - Short Version (Shakespear-Druery et al., 2022)

    Measured: Week 4

  108. Muscle-Strengthening Exercise Activity

    Muscle-Strengthening Exercise Questionnaire - Short Version (Shakespear-Druery et al., 2022)

    Measured: Week 8

  109. Muscle-Strengthening Exercise Activity

    Muscle-Strengthening Exercise Questionnaire - Short Version (Shakespear-Druery et al., 2022)

    Measured: Week 12

Timeline

From the start of the study to its completion; the mark is today. Estimated dates are the sponsor’s plan.

  1. First posted3 Feb 2025
  2. Study start9 Oct 2023
  3. Primary completion5 Jan 2025
  4. Study completion5 Jan 2025

Resources

More details

For doctors and researchers: how the study is designed, who runs it, and its registry IDs.

Study design
Study type
Interventional
Phase
Phase N/A
Primary purpose
Other
Allocation
Randomised
Intervention model
Parallel groups
Model description
Parallel group randomized controlled trial of ten weeks of moderate-to-high compared to low intensity SHAM resistance exercise training among young adult women with analogue Generalized Anxiety Disorder
Masking
Double blind
Who is masked
Investigator, Outcomes assessor
Enrolment
68 participants (actual)
IDs, dates and publications
ClinicalTrials.gov ID
NCT06804629
Sponsor's protocol ID
2017_03_18_EHS_new
Other IDs
GOIPG/2023/4158
Acronym
RETRAIN REP-EX
Status last verified
Jan 2025
First submitted
20 Jan 2025
Last updated
3 Feb 2025
Results posted
No
Data monitoring committee
No
FDA-regulated drug
No
FDA-regulated device
No
Individual data sharing
Yes: De-identified individual participant data for all primary and secondary outcomes measures will be made available.

Questions about this trial

What is this clinical trial studying?

A study testing Moderate-to-High Intensity Resistance Exercise Training in people with Analogue Generalized Anxiety Disorder, run by University of Limerick at 1 site in Ireland.

The full registered description is in the About this study section and the official record.

Who may be eligible to take part?

The sponsor lists 3 inclusion and 3 exclusion criteria. Eligibility is decided by the study team after screening, so read the full criteria and contact a listed site.

Is this clinical trial currently recruiting?

The record says: finished, as of the sponsor's last update on 3 Feb 2025. Status can change between updates, so confirm with the study contact before making plans.

Where is the study taking place?

The record lists 1 site in Ireland. Whether a site is taking part right now should be confirmed with that site. See every site.

What are the possible benefits and risks?

They depend on the study and the treatment, and no study can promise a benefit. Some participants in this study may receive a placebo. The study team explains the known risks during informed consent, before anyone joins; the record itself does not list them.

Are results available for this study?

The study is completed, but results are not available in the source record. That does not mean the treatment did or did not work.

How can a doctor refer a patient or contact the research team?

The record lists no contact. The official record names the sponsor, who can be asked directly. AzTrials does not enrol participants or take referrals.

What does the primary outcome measure?

Analogue Generalized Anxiety Disorder Status (time frame: Baseline). The study lists 21 primary outcomes in all. It is what the study was designed to measure, not a finding.

Where can I read the original study information?
Does a listing mean the treatment is approved or proven to work?

No. A listing means the study is registered. It does not show that the treatment is safe, works, or is approved by a regulator.

How often is this information updated?

AzTrials copies changed records from ClinicalTrials.gov every night and reloads the whole registry every week. The sponsor last updated this record on 3 Feb 2025.

Free account

Keep searching with a free account

You’ve used your 3 free searches for this session. Log in or create a free AzTrials account to keep searching clinical trials and save the ones you want to follow.

Create a free accountLog in